Literature DB >> 2066357

Gene expression of cytokines suppressing hematopoietic progenitor cells in lymphoid malignancies.

C Kawasaki1, S Okamura, S Hayashi, S Kondo, M Harada, Y Niho.   

Abstract

The expression of cytokine genes for tumor necrosis factor alpha (TNF alpha), lymphotoxin and transforming growth factor beta (TGF beta), all of which are known to suppress normal hematopoiesis, was investigated in 32 patients with lymphoid malignancies using Northern blot analysis. Messenger RNA (mRNA) for TNF alpha, lymphotoxin and TGF beta was detected in 9 cases, 2 cases and 7 cases, respectively. When the relationship between cytokine gene expression and surface phenotype was analyzed, the expression of CD19 correlated significantly with expression of the TNF alpha gene (P less than 0.05). This suggests that B cell malignancies are likely to produce TNF alpha. When the hematological parameters of patients expressing and not expressing the gene were compared, the expression of TNF alpha mRNA was found to correlate with more profound anemia in acute lymphoblastic leukemia (P less than 0.05). Both granulocyte and platelet counts were lower in patients expressing TNF alpha mRNA; however, the decreases were not significant. Neither lymphotoxin nor TGF beta gene expression correlated significantly with any hematological parameter.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2066357     DOI: 10.1007/BF01630720

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  28 in total

1.  Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma.

Authors:  M Kawano; H Tanaka; H Ishikawa; M Nobuyoshi; K Iwato; H Asaoku; O Tanabe; A Kuramoto
Journal:  Blood       Date:  1989-06       Impact factor: 22.113

2.  Stimulation and inhibition of human granulopoiesis in vitro by normal and malignant T4- or T8-lymphocyte subpopulations.

Authors:  T Bonnefoix; J J Sotto; B Pegourie; M P Piccinni
Journal:  Exp Hematol       Date:  1987-07       Impact factor: 3.084

3.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

4.  Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia.

Authors:  W Digel; M Stefanic; W Schöniger; C Buck; A Raghavachar; N Frickhofen; H Heimpel; F Porzsolt
Journal:  Blood       Date:  1989-04       Impact factor: 22.113

5.  The suppressive effects of recombinant human tumor necrosis factor-alpha on normal and malignant myelopoiesis: synergism with interferon-gamma.

Authors:  F Herrmann; T Bambach; R Bonifer; A Lindemann; D Riedel; W Oster; R Mertelsmann
Journal:  Int J Cell Cloning       Date:  1988-07

6.  Expression of cytokine genes in hematological malignancies.

Authors:  S Okamura; S Hayashi; C Kawasaki; S Kondo; Y Asano; F Omori; T Otsuka; T Shibuya; M Harada; Y Niho
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1989-12

7.  Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies.

Authors:  F T Cordingley; A Bianchi; A V Hoffbrand; J E Reittie; H E Heslop; A Vyakarnam; M Turner; A Meager; M K Brenner
Journal:  Lancet       Date:  1988-04-30       Impact factor: 79.321

8.  B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.

Authors:  L M Nadler; K C Anderson; G Marti; M Bates; E Park; J F Daley; S F Schlossman
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

9.  Expression of different combinations of interleukins by human T cell leukemic cell lines that are clonally related.

Authors:  T Noma; H Nakakubo; M Sugita; S Kumagai; M Maeda; A Shimizu; T Honjo
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

10.  Secretion of transforming growth factor-beta by human myelogenous leukemic cells and its possible role in proliferation of the leukemic cells.

Authors:  K Komatsu; H Nakamura; K Shinkai; H Akedo
Journal:  Jpn J Cancer Res       Date:  1989-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.